Abstract:Key PointsAtherothrombotic vascular disease (ATVD) is the leading cause of death in the industrialized world, and this problem is growing owing to the increase in obesity and insulin resistance worldwide. ATVD develops as a macrophage-dominant maladaptive inflammatory response to subendothelial lipoproteins.A fundamental aspect of this maladaptive inflammatory response is a failure to resolve inflammation, which normally involves the suppression of inflammatory cell influx, effective phagocytic clearance of apoptotic cells and promotion of inflammatory cell egress. The mechanism of failed inflammation resolution in atherosclerosis is not known, but it is likely to involve defective generation or action of anti-inflammatory cytokines (for example, interleukin-10), pro-resolution lipid mediators (for example, lipoxins) and transcription factors (for example, the liver X receptor family) that normally carry out this process.In advanced atherosclerosis, there is continual recruitment of inflammatory monocytes, and the macrophages that differentiate from these monocytes in lesions may favour the classically activated (M1) subtype, which promote inflammation, over the alternatively activated (M2) subtype, which participate in inflammation resolution. Egress of inflammatory macrophages in advanced atherosclerotic lesions is also defective.Macrophage apoptosis coupled with defective clearance of these apoptotic cells (efferocytosis) in advanced atherosclerotic lesions is a particularly important process because it leads to the generation of plaque necrosis, which is a key feature of the types of atherosclerotic lesions that cause ATVD. One key mechanism of macrophage apoptosis in this setting is a pathway in which the endoplasmic reticulum stress pathway known as the unfolded protein response, perhaps in combination with pattern recognition receptor activation, triggers Ca2+-dependent apoptosis.The mechanisms of defective efferocytosis in advanced atheroma are not known, but may involve deficiency, dysfunction and/or competitive inhibition of receptors, ligands and other factors involved in apoptotic cell recognition and engulfment.The ability to translate the complex process of plaque progression into an integrated molecular and cellular concept of defective inflammation resolution provides a useful way to understand how atherosclerosis leads to clinical disease and how plaque progression may be prevented by new therapeutic approaches.

Macrophage Apoptosis and Efferocytosis in the Pathogenesis of Atherosclerosis

Mechanisms and consequences of macrophage apoptosis in atherosclerosis

Macrophage death and defective inflammation resolution in atherosclerosis

Macrophage death in atherosclerosis: potential role in calcification

Macrophage Apoptosis Exerts Divergent Effects on Atherogenesis as a Function of Lesion Stage

Mechanism of efferocytosis in atherosclerosis

Programmed death of macrophages in atherosclerosis: mechanisms and therapeutic targets

Macrophage-Mediated Mechanisms In Atherosclerosis: Still Tangled

Acid Sphingomyelinase Mediates Oxidized-LDL Induced Apoptosis in Macrophage Via Endoplasmic Reticulum Stress

Redistribution Of Intracellular Calcium And Its Effect On Apoptosis In Macrophages: Induction By Oxidized Ldl

Molecular and cellular mechanisms of macrophage survival in atherosclerosis

Novel insight on the role of Macrophages in atherosclerosis: Focus on polarization, apoptosis and efferocytosis

Apoptosis Signal–Regulating Kinase 1 Deficiency Accelerates Hyperlipidemia-Induced Atheromatous Plaques Via Suppression of Macrophage Apoptosis

Macrophage Subsets and Death Are Responsible for Atherosclerotic Plaque Formation

Depletion of β-arrestin-1 in macrophages enhances atherosclerosis in ApoE−/− mice

Selective Inhibition Of Pi3k/Akt/Mtor Signaling Pathway Regulates Autophagy Of Macrophage And Vulnerability Of Atherosclerotic Plaque

The regulation of Ero1-alpha in homocysteine-induced macrophage apoptosis and vulnerable plaque formation in atherosclerosis

Mitochondria and AMP-activated protein kinase-dependent mechanism of efferocytosis

Abstract Tu014: Endoplasmic reticulum stress exacerbates atherosclerosis via microRNA-181a by inhibiting mitophagy

Macrophage Anti-inflammatory Behaviour in a Multiphase Model of Atherosclerotic Plaque Development

Exploiting macrophage autophagy-lysosomal biogenesis as a therapy for atherosclerosis